EF
LLY icon

Empowered Funds’s Eli Lilly LLY Stock Holding History

Empowered Funds’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166M Buy
138,183
+297
+0.2% +$303K 0.87% 9
2026
Q1 		$127M Buy
+137,886
New +$140M 0.81% 11
2025
Q4 		– Sell
-55,238
Closed -$42.1M – 1509
2025
Q3 		$42.1M Buy
55,238
+11,894
+27% +$8.85M 0.43% 26
2025
Q2 		$33.8M Buy
43,344
+8,930
+26% +$6.94M 0.38% 35
2025
Q1 		$28.4M Sell
34,414
-427
-1% -$355K 0.4% 28
2024
Q4 		$26.9M Buy
34,841
+3,045
+10% +$2.52M 0.39% 29
2024
Q3 		$28.2M Sell
31,796
-1,520
-5% -$1.37M 0.44% 26
2024
Q2 		$30.2M Buy
33,316
+1,289
+4% +$1.03M 0.52% 22
2024
Q1 		$24.9M Buy
32,027
+2,452
+8% +$1.75M 0.45% 29
2023
Q4 		$17.2M Buy
29,575
+7,229
+32% +$4.22M 0.43% 23
2023
Q3 		$12M Buy
22,346
+1,464
+7% +$754K 0.35% 35
2023
Q2 		$9.79M Sell
20,882
-7,268
-26% -$3.05M 0.34% 36
2023
Q1 		$9.67M Buy
28,150
+2,830
+11% +$954K 0.57% 28
2022
Q4 		$9.26M Buy
25,320
+16,701
+194% +$5.92M 0.61% 28
2022
Q3 		$2.79M Sell
8,619
-2,669
-24% -$846K 0.27% 95
2022
Q2 		$3.66M Buy
11,288
+6,812
+152% +$2.04M 0.47% 77
2022
Q1 		$1.28M Buy
4,476
+510
+13% +$131K 0.14% 167
2021
Q4 		$1.09M Buy
3,966
+630
+19% +$160K 0.12% 154
2021
Q3 		$771K Buy
3,336
+1,160
+53% +$286K 0.1% 140
2021
Q2 		$499K Buy
+2,176
New +$437K 0.06% 172
2019
Q3 		– Sell
-9,719
Closed -$1.08M – 109
2019
Q2 		$1.08M Sell
9,719
-1,951
-17% -$230K 0.45% 88
2019
Q1 		$1.51M Buy
+11,670
New +$1.42M 0.54% 61

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Empowered Funds's LLY Position: Q2 2026 in Review

Empowered Funds increased its Eli Lilly (LLY) stake by 0.22% in Q2 2026, buying an estimated $303K and bringing the position to 138,183 shares worth $166M. The position accounts for 0.87% of the portfolio, ranked #9.

Empowered Funds first reported a position in LLY in Q1 2019 and has held it in 22 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Empowered Funds held 138,183 shares of Eli Lilly worth $166M as of Q2 2026.
  • Empowered Funds bought 297 Eli Lilly shares in Q2 2026, an estimated $303K.
  • Eli Lilly made up 0.87% of Empowered Funds's portfolio in Q2 2026, its #9 holding.
  • Empowered Funds first reported a position in Eli Lilly in Q1 2019 and has held it in 22 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.